Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457819 · ClinicalTrials.gov registry record · Phase 3
Dasotraline Pediatric Extension Study
A Phase 3 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 3
- Development phase
- 237
- Enrollment target
NCT02457819 is a Phase 3 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 237 participants.
The verdict
NCT02457819, a Phase 3 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 237 participants
- Enrollment target
Study Summary
This is an open label 26 week extension study for subjects who completed SEP360-202.
Interventions
- DRUG Dasotraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2015-06-30 |
| Est. Completion | 2017-02-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02457819
The ClinicalTrials.gov registry entry for NCT02457819 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dasotraline is the first listed.
NCT02457819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02457819 about?
NCT02457819 is a clinical study titled "Dasotraline Pediatric Extension Study". This is an open label 26 week extension study for subjects who completed SEP360-202.
What is the current status of trial NCT02457819?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 237 participants. The study started on 2015-06-30. Estimated completion is 2017-02-02.
What interventions are being tested in trial NCT02457819?
The interventions under investigation include: Dasotraline (DRUG).
Who is sponsoring clinical trial NCT02457819?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.